Previous studies have confirmed that some biological markers can also be used in the diagnosis of CHD, such as interleukin (IL), tumor necrosis factor (TNF), and nuclear transcription factor-κB (NF-κB). The gene discussed is NFKB1; the disease is coronary artery disorder.